New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
FDA clearance for non-muscle invasive bladder cancer treatment
New mass spec platform launched
Approval for prostate cancer treatment
Approval for atopic dermatitis treatment
FDA Breakthrough Therapy Designation for Glanzmann Thrombasthenia drug
New company targets dry eye disease with first-in-class therapy
Collaboration to advance novel combination therapy for glioblastoma
Study shows AI boosts breast cancer detection by more than 10 percent
First reliable biomarker test for early kidney transplant rejection detection in living-donor recipients